ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,135Medicare Part D Prescriptions Filled, Including Refills

Rank: 81 out of 1006

$667K Total Retail Price of All Prescriptions

Rank: 119 out of 1006

356 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 356 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 356 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 10,561 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 450 439 1 6
TRAZODONE HCL 423 423 2 21
AMLODIPINE BESYLATE 332 318 3 4
LEVOTHYROXINE SODIUM 316 298 4 2
METOPROLOL TARTRATE 289 288 5 7
DONEPEZIL HCL 274 250 6 17
ESCITALOPRAM OXALATE 246 243 7 27
METOPROLOL SUCCINATE 242 240 8 12
SERTRALINE HCL 222 220 9 19
WARFARIN SODIUM 206 206 10 8
HYDROCODONE-ACETAMINOPHEN 204 187 S3 11 25
ATORVASTATIN CALCIUM 184 168 12 5
OMEPRAZOLE 184 158 12 9
METFORMIN HCL 171 158 14 10
POTASSIUM CHLORIDE 169 168 15 30
SIMVASTATIN 167 154 16 1
VERAPAMIL ER 167 157 16 116
PREDNISONE 164 161 18 33
NAMENDA 155 154 19 34
ATENOLOL 142 142 20 13
RISPERIDONE 131 94 21 40
TAMSULOSIN HCL 129 129 22 23
MIRTAZAPINE 124 120 23 26
HYDROCHLOROTHIAZIDE 122 109 24 11
CELEBREX 118 115 25 90
DIGOXIN 104 104 26 52
ZOLPIDEM TARTRATE 102 102 27 14
CITALOPRAM HBR 101 101 28 24
GENERLAC 95 95 29 140
FINASTERIDE 90 90 30 76
FLUOXETINE HCL 89 77 31 85
PAROXETINE HCL 88 88 32 62
CYMBALTA 86 86 33 41
ISOSORBIDE MONONITRATE ER 84 82 34 59
LISINOPRIL 82 78 35 3
AMILORIDE-HYDROCHLOROTHIAZIDE 78 78 36 267
TRAMADOL HCL 78 77 36 35
RAMIPRIL 78 78 36 79
CLOPIDOGREL 77 74 39 46
RANITIDINE HCL 77 77 39 63
DIOVAN 75 75 41 16
QUETIAPINE FUMARATE 72 66 42 45
OLANZAPINE 70 58 43 68
ALLOPURINOL 69 64 44 31
OXYCODONE HCL 67 65 S2 45 54
LYRICA 66 65 46 115
NIFEDIPINE ER 66 53 46 166
FENTANYL 62 61 S2 48 74
LACTULOSE 57 45 49 104
LEXAPRO 57 55 49 103
POLYETHYLENE GLYCOL 3350 57 52 49 91
CARBIDOPA-LEVODOPA 56 56 52 80
FLUDROCORTISONE ACETATE 55 55 53 303
LIPITOR 53 43 54 47
PANTOPRAZOLE SODIUM 50 50 55 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.